Nikita Mehra

Biographic Data

ID9066464
NAMENikita Mehra
GIVEN NAMESNikita
FAMILY NAMEMehra
SIGNATUREMEHRA N
AFFILIATIONSCancer Institute (WIA)
ORCID0000-0002-4605-7470
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR1
WORKS AS EDITOR4
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2023
H-INDEX0

  • Financial toxicity of cancer treatment in India

    Open AccessShankar Prinja, Jyoti Dixit et al.ARTICLEFrontiers in Public Health2023

    Background The rising economic burden of cancer on patients is an important determinant of access to treatment initiation and adherence in India. Several publicly financed health insurance (PFHI) schemes have been launched in India, with treatment for cancer as an explicit inclusion in the health benefit packages (HBPs). Although, financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known a…

  • Smartphone-operated affordable PCR thermal cycler for the detection of antimicrobial resistant bacterial genes

    Open AccessSanam Pudasaini, Garima Thapa et al.EDITORARTICLEPLOS Global Public Health2023

    Antimicrobial resistance (AMR) is a global public health threat. Surveillance of AMR requires affordable, rapid, and user-friendly diagnostic methods. Our aim was to develop a low-cost thermocycler to perform polymerase chain reaction (PCR). We developed a smartphone-operated PCR thermal cycler using locally available recycled materials. The thermal cycler was used for the amplification for three bacterial genes– bla-TEM , bla-CTXM and 16s rRNA i…

  • Calculating worldwide needs for morphine for pain in advanced cancer and proportions feasibly met by country estimates of requirements and consumption. Retrospective, time-series analysis (1997–2017)

    Open AccessJoseph Clark, Lucia Crowther et al.EDITORARTICLEPLOS Global Public Health2022

    Lack of access to therapeutic opioids continuing causes global health inequalities. Access to morphine for symptom control is regulated under the terms of the Single Convention on Narcotics, countries must submit annual morphine requirement estimates and report consumption to the International Narcotics Control Board (INCB). INCB indicates access to morphine is increasing, however, estimated needs are unreported so changing proportions of needs f…

  • Region-specific laboratory reference intervals are important

    Open AccessMatt A Price, Patricia E Fast et al.EDITORARTICLEPLOS Global Public Health2022

    Region-specific laboratory reference intervals (RIs) are important for clinical trials and these data are often sparse in priority areas for research, including Africa. We reviewed data on RIs from Africa to identify gaps in the literature with a systematic review of PubMed for RI studies from Africa published ≥2010. Search focus included clinical analytic chemistry, hematology, immunological parameters and RIs. Data from adults, adolescents, chi…

  • Rare disease patients in India are rarely involved in international orphan drug trials

    Open AccessMonoswi Chakraborty, Mohua Chakraborty Choudhury et al.EDITORARTICLEPLOS Global Public Health2022

    We wished to determine whether rare diseases patients from India had been enrolled in international trials to develop novel orphan drugs. There are two reasons to be interested in this. (a) Different ethnic or racial groups may respond differently to a particular drug. India has huge ethnic diversity, and to exclude such participants is to severely limit the diversity of any trial; (b) Even if a suitable drug for a rare disease is available in In…